Back
Ligand Pharmaceuticals Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Buy
60
LGND
Ligand Pharmaceuticals
Last Price:
114.04
Seasonality Move:
12.9%
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
821.99
Seasonality Move:
11.8%
Buy
60
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $111.13. The Score for LGND is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $829.43. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $111.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $829.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 57.9 | Buy |
Chaikin Money Flow: | 62382 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (102.29 - 110.57) | Buy |
Bollinger Bands (100): | (91.02 - 108.76) | Buy |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -57.31 | Sell |
Relative Strength Index (14 RSI): | 13.94 | Sell |
Chaikin Money Flow: | 109670 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (895.28 - 1026.78) | Sell |
Bollinger Bands (100): | (983.53 - 1152.51) | Sell |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.95 | Buy |
20-day SMA: | 107.48 | Buy |
50-day SMA: | 104.59 | Buy |
200-day SMA: | 88.4 | Buy |
8-day EMA: | 109.98 | Buy |
20-day EMA: | 108.03 | Buy |
50-day EMA: | 104.74 | Buy |
200-day EMA: | 91.45 | Buy |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 881.48 | Sell |
20-day SMA: | 945.74 | Sell |
50-day SMA: | 1047.97 | Sell |
200-day SMA: | 1011.95 | Sell |
8-day EMA: | 873.49 | Sell |
20-day EMA: | 932.64 | Sell |
50-day EMA: | 1004.92 | Sell |
200-day EMA: | 999.95 | Sell |
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.84 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $0.75 per share.
Ligand Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |